None listed
Conditions
Brief summary
This study aims to evaluate the effectiveness of a brief psychosocial intervention in reducing depression and anxiety in patients with cancer. Who is it for? You can join this study if you are aged 18 years or more and have a diagnosis of cancer for which you are attending any of the participating clinical sites for treatment. Patients already receiving current specialised psychological treatments or taking antidepressant medication will not be eligible. Trial details Eligible patients who have mild to moderate depression/distress and/or risk factors for becoming depressed will undergo a maximum of 4 x 30 minute tailored psychosocial therapy sessions over a period of 4 weeks. The type of therapy will vary depending on the each patient's needs, examples of which include practical concerns (e.g. finances), family concerns (e.g. child care), emotional concerns (e.g. anxiety about chemotherapy) physical concerns (e.g. pain), and spiritual concerns (e.g. shame). The psychosocial therapy will be delivered by health professionals who have undergone special training. Patients with low distress or risk factors will receive a patient self-directed resource kit comprising materials demonstrated to be acceptable and effective for patients with cancer. Patients who have no distress and no risk factors for the development of depression will continue to receive usual medical treatment. Participants will complete questionnaires at baseline and 10 weeks to assess depression, anxiety, unmet needs, and quality of life.
Interventions
Patients who have low to mild distress or who have risk factors for becoming depressed will receive a self-directed resource suite which includes handbooks on coping with cancer, a relaxation CD, information about coping with stress and other information about topics such as sleep hygiene and exercise. Information is included about the availability of support through the Cancer Helpline. Patients who have mild to moderate depression/distress and/or risk factors for becoming depressed and a HADS score of 8 to 21 inclusive will receive tailored psychosocial therapy, aligned with patient needs as identified on patient self-report on the Distress Thermometer. The precise type of psychosocial therapy will vary depending on patient need, examples of which include: i) Practical concerns such as about finances; difficulty with domestic tasks: Therapy may include referral to Social Work; clarification of concerns; structured problem-solving; challenging black and white thinking about the need to perform domestic tasks; re-assigning priorities. ii) Family - concerns about children: Therapy components may include empathic listening; acknowledgment of concerns; explanation about children's needs; discussion about the benefits of maintaining routine; reassuring children that they have not caused the cancer. iii) Emotional concerns, for example anxiety about chemotherapy: Therapy may include explanation and provision of information; identification of automatic thoughts; challenging negative cognitions; relaxation and guided imagery. iv) Physical concerns such as pain: Therapy would include referral for medical review; exploration of concerns about pain; identifying and challenging misbeliefs e.g. about becoming dependent on analgesia or that use of morphine implies inevitably poor prognosis; relaxation and guided imagery. v) Spiritual concerns such as shame about dependence, low sense of worth: Therapy would include dignity-conserving techniques e.g. exploration of past experiences, reflection on strengths; engaging in creative discussion about ways to feel in control; framing assistance as necessary to maintain dignity. The psychosocial therapy will be delivered by health professionals from diverse backgrounds including nursing, radiation therapy or speech therapy who have undergone focused training. The training will be delivered through a structured self-directed educational manual, supplemented with a day-long skill development training session faciliated by one of the psychiatrist investigators at the specific Site. The duration of the training for participating health professionals will be approximately 10 weeks. During the delivery of the psychosocial therapy, all health professionals will participate in weekly clinical supervision conducted in group format with other participating health professionals at the respective Site, facilitated by one of the psychiatrist investigators, in order to monitor progress and ensure fidelity of the psychosocial intervention. The therapy sessions will each be of maximum 30 minutes' duration, for a maximum of 4 sessions, delivered over 4 weeks. The therapy may be delivered face-to-face or by telephone depending on patient and health professional convenience. Patients receiving the psychosocial therapy will also receive the self-directed resource suite described above.
Sponsors
Study design
Eligibility
Inclusion criteria
Patients eligible for this study must have a diagnosis of cancer and be attending any of the participating clinical Sites for medical review or treatment. Aged 18 years or over Consecutive patients attending outpatient oncology clinics at each Site Are currently receiving active treatment for cancer OR Have completed active treatment within the previous 2 months OR Have been diagnosed with recurrent/advanced cancer within the previous 2 months
Exclusion criteria
Inability to speak and read English; Receiving current specialised psychological treatment from a psychologist, psychiatrist, or other trained counsellor; Currently taking antidepressant medication; Health status precludes ability to complete questionnaires and participate in up to four (4) psychosocial Intervention sessions, and follow-up at 10 weeks; Recruited in any previous Epoch of this study (ie patients can only participate during one Epoch)